The Beijing Institute of Genomics (BIG) of the Chinese Academy of Sciences has acquired eight additional Life Technologies’ SOLiD™ Systems for a variety of genomics studies.
The SOLiD System is the company’s next-generation genomic analysis platform for DNA sequencing and RNA analysis applications. BIG is concentrating its research activities on genomics and bioinformatics, based on its genomics technology platforms and its long-term goal to transform original raw genomics data to useful information and knowledge for life science research.
As part of this effort, BIG is expanding its fleet of SOLiD Systems to a total of nine, with plans to explore mutation profiling of cancer genes, investigations of genetic variation in model organisms, metagenomic analysis of microbes, and discovery and characterization of novel microRNAs. Use of high-throughput genomic analysis technologies such as the SOLiD System, generate vast amounts of data, which scientists analyze to gain a better understanding of how somatic mutations contribute to disease, such as tumor proliferation, explains Chung-I Wu, Ph.D., director of BIG.
“The Beijing Institute of Genomics plays an important role in producing and analyzing complex genomic data. DNA resequencing is the cornerstone of our discoveries and we invest in new technologies to develop a more comprehensive view of biological variation,” he says. “We will benefit from the throughput, flexibility, and sensitivity of these [SOLiD] systems, which we expect will contribute greatly to major genomic initiatives, such as resequencing, to identify pathogen genomics and genetics, cancer genetics, and to conduct individual research programs within the Institute.”